AAIC 2025 Abstract
Florzolotau Tau PET for the prediction of clinical progression in the Shanghai Memory Study
Study in peopleBiomarkers
Abstract
Background: Clinical‐biological diagnosis of Alzheimer's disease (AD) is gaining increasing recognition. Beyond diagnosis, biological profiles can be of great benefit for disease monitoring and prognosis, although evidence from real‐world memory clinics is still limited.
